Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
7.04
+0.03 (0.43%)
Aug 3, 2026, 4:00 PM EDT - Market closed
Aura Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 |
Selling, General & Admin | 23.71 | 22.49 | 22.62 | 23.09 | 23.24 | 22.81 | 21.84 | 20.71 | 19.98 | 19.76 | 19.71 | 19.41 | 18.56 | 18.06 | 17.25 | 15.02 | 12.88 | 10.09 | 7.81 | 6.06 |
Research & Development | 94.92 | 90.3 | 90.74 | 85.6 | 79.59 | 73.3 | 71.25 | 69.64 | 67.88 | 65.23 | 58.11 | 53.98 | 48.37 | 42.24 | 37.06 | 32.13 | 29.25 | 25.16 | 20.73 | 17.21 |
Total Operating Expenses | 118.62 | 112.79 | 113.36 | 108.69 | 102.84 | 96.12 | 93.09 | 90.35 | 87.86 | 84.99 | 77.82 | 73.39 | 66.93 | 60.3 | 54.31 | 47.15 | 42.13 | 35.25 | 28.53 | 23.27 |
Operating Income | -118.62 | -112.79 | -113.36 | -108.69 | -102.84 | -96.12 | -93.09 | -90.35 | -87.86 | -84.99 | -77.82 | -73.39 | -66.93 | -60.3 | -54.31 | -47.15 | -42.13 | -35.25 | -63.13 | -50.6 |
Interest Income | 5.04 | 6.63 | 7.12 | - | - | 9.43 | 10 | 9.72 | 9.28 | 8.59 | 7.04 | 5.55 | 3.83 | 1.86 | 0.81 | 0.33 | 0.04 | 0.01 | - | - |
Interest Expense | 1.19 | 1.59 | 1.59 | 1.59 | 1.59 | - | - | - | - | - | - | - | - | - | - | - | - | -0 | -0 | -0 |
Other Non-Operating Income (Expense) | -0.05 | 0 | -0.07 | -0.09 | -0.08 | -0.2 | -0.11 | -0.09 | -0.1 | 0.09 | 0.27 | -0.06 | 0.02 | -0.33 | -0.32 | 0.06 | -0.06 | -0.07 | -0.05 | -0.05 |
Total Non-Operating Income (Expense) | 6.33 | 6.71 | 7.01 | 7.44 | 8.23 | 9.31 | 10.1 | 9.84 | 9.4 | 8.72 | 6.99 | 5.16 | 3.53 | 1.53 | 0.47 | 0.37 | -0.03 | -0 | 0.01 | -0.05 |
Pretax Income | -112.29 | -106.08 | -106.35 | -101.25 | -94.61 | -86.81 | -82.99 | -80.5 | -78.47 | -76.27 | -70.84 | -68.23 | -63.39 | -58.76 | -53.84 | -46.78 | -42.16 | -35.25 | -63.12 | -50.65 |
Provision for Income Taxes | -0.1 | -0.11 | -0.12 | -0.13 | -0.09 | -0.11 | -0.23 | -0.18 | -0.18 | -0.14 | - | - | - | - | - | - | - | - | - | - |
Net Income | -112.39 | -106.19 | -106.47 | -101.38 | -94.7 | -86.92 | -83.22 | -80.69 | -78.65 | -76.41 | -70.84 | -68.23 | -63.39 | -58.76 | -53.84 | -46.78 | -42.16 | -35.25 | -63.12 | -50.65 |
Net Income to Common | -112.39 | -106.19 | -106.47 | -101.38 | -94.7 | -86.92 | -83.22 | -80.69 | -78.65 | -76.41 | -70.84 | -68.23 | -63.39 | -58.76 | -66.79 | -72.23 | -80.09 | -81.44 | -40.28 | -33.35 |
Net Income Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding (Basic) | 65 | 60 | 56 | 52 | 50 | 50 | 49 | 47 | 44 | 40 | 38 | 36 | 34 | 30 | 27 | 20 | 12 | 5 | 0 | 0 |
Shares Outstanding (Diluted) | 65 | 60 | 56 | 52 | 50 | 50 | 49 | 47 | 44 | 40 | 38 | 36 | 34 | 30 | 27 | 20 | 12 | 5 | 0 | 0 |
Shares Change (YoY) | 29.72% | 21.52% | 13.33% | 11.58% | 14.20% | 25.32% | 28.50% | 28.48% | 28.01% | 32.34% | 43.63% | 85.15% | 175.64% | 480.18% | 6351.84% | 4806.19% | 2739.37% | 1305.21% | 27.29% | - |
EPS (Basic) | -1.74 | -1.76 | -1.94 | -1.96 | -1.90 | -1.75 | -1.67 | -1.73 | -1.80 | -1.93 | -1.88 | -1.94 | -1.92 | -1.96 | 67.54 | 39.75 | 11.68 | -8.95 | -95.85 | -82.33 |
EPS (Diluted) | -1.74 | -1.76 | -1.94 | -1.96 | -1.90 | -1.75 | -1.67 | -1.73 | -1.80 | -1.93 | -1.88 | -1.94 | -1.92 | -1.96 | 67.54 | 39.75 | 11.68 | -8.95 | -95.85 | -82.33 |
EPS Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Additional Metrics
Fiscal Quarter | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 |
Free Cash Flow | -91.64 | -85.19 | -88.8 | -84.22 | -80.06 | -81.06 | -74.51 | -74.39 | -72.58 | -64.56 | -65.22 | -60.55 | -56.42 | -55.7 | -50.23 | -48.67 | -45.13 | -34.54 | -25.52 | -22.97 |
Free Cash Flow Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Free Cash Flow Per Share | -1.42 | -1.41 | -1.59 | -1.62 | -1.61 | -1.63 | -1.51 | -1.60 | -1.66 | -1.63 | -1.70 | -1.67 | -1.66 | -1.86 | -1.88 | -2.49 | -3.65 | -6.69 | -61.49 | -57.59 |
EBITDA | -117.51 | -111.66 | -112.21 | -107.51 | -101.63 | -94.89 | -91.83 | -89.06 | -86.59 | -83.7 | -76.53 | -72.14 | -65.68 | -59.12 | -53.23 | -46.15 | -41.23 | -34.42 | -62.3 | -49.76 |
EBIT | -118.62 | -112.79 | -113.36 | -108.69 | -102.84 | -96.12 | -93.09 | -90.35 | -87.86 | -84.99 | -77.82 | -73.39 | -66.93 | -60.3 | -54.31 | -47.15 | -42.13 | -35.25 | -63.13 | -50.6 |
Effective Tax Rate | 0.09% | 0.10% | 0.11% | 0.13% | 0.09% | 0.13% | 0.27% | 0.23% | 0.23% | 0.18% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |